Respiratory syncytial virus (RSV) vaccine available for eligible pregnant women under the NIP in 2025
In 2025, eligible pregnant women will be able to receive the respiratory syncytial virus (RSV) vaccine for free under the National Immunisation Program (NIP).
The RSV vaccine is for women at 28 to 36 weeks of pregnancy. It protects their newborn child from the virus.
RSV is a serious disease for newborn babies. It infects the nose, throat, and lungs and is a leading cause of childhood hospitalisation.
Adding the RSV vaccine to the NIP in 2025 will be an important step towards ensuring there is a consistent national approach to protecting babies from the virus.
Patients are eligible for a free National Immunisation Program (NIP) vaccine if they have, or are eligible for, a Medicare card.
The start date for the program is coming soon. For more information, please see the Department of Health and Aged Care website.